A research team led by Dr. Martin Mollenhauer from the Heart Center at University Hospital Cologne has investigated the link ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in ...

A preclinical study by scientists at Scripps Research finds that a drug already FDA-approved for treating inflammatory ...

Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to scientists. By engineering human ...

The incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) has been escalating annually, positioning ...

Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

Inside cells, two important enzymes act like small central regulatory hubs: dipeptidyl peptidase 8 and 9—DPP8/9 for short.

This phenomenon is commonly observed in liver surgeries, liver transplants, trauma, or the treatment of ... regulating apoptosis, inflammatory responses, and mitochondrial function. Poly(ADP-ribose) ...

Nattokinase is an enzyme (protein) found in natto ... May Protect Brain Health Nattokinase shows promise as a potential therapy for Alzheimer's disease and other neurologic diseases. Though research ...

Some soothe your skin or cool it down, while others reduce inflammation and itching while ... disappear within a few days of starting home treatment. The rate it takes to disappear depends on ...